Genetic discoveries drive new approaches to treating cerebral vascular malformations

Cerebral vascular malformations (CVMs), including cerebral arteriovenous malformations (AVMs) and cavernous malformations (CCMs), have long posed challenges due to their complex origins and severe clinical implications.

Nuclera closes $75 million USD financing

Nuclera, the biotechnology company accelerating protein expression and purification workflows through its benchtop protein system, today announced it has completed a USD $75 million financing

October 16, 2024

Nixing the X Waiver Hasn’t Yet Vastly Expanded Buprenorphine Access

While the elimination of the X waiver increased the number of clinicians prescribing buprenorphine, it hasn’t yet had a substantial impact on the number of

April 25, 2024

FDA officials outline benefits of AI lifecycle management

Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: Food and Drug Administration officials

July 30, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.